Rapid Micro Biosystems (RPID) EBT Margin (2020 - 2026)

Rapid Micro Biosystems has disclosed EBT Margin across 7 years of filings, most recently posting 178.29% for Q1 2026.

• EBT Margin for Q1 2026 came in at 178.29%, down 2207.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 145.69% (up 545.0% YoY), and the FY2025 annual result was 140.18%, up 2690.0% from the prior year.
• EBT Margin came in at 178.29% for Q1 2026 at Rapid Micro Biosystems, down from 110.65% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 110.65% in Q4 2025 to a low of 375.86% in Q4 2022.
• The 5-year median for EBT Margin is 189.83% (2024), against an average of 225.42%.
• Across the five-year window, EBT Margin sank 16229 bps in 2022 and soared 19969 bps in 2023, its largest moves.
• Rapid Micro Biosystems' EBT Margin stood at 375.86% in 2022, then jumped by 53 bps to 176.17% in 2023, then surged by 33 bps to 117.73% in 2024, then gained by 6 bps to 110.65% in 2025, then sank by 61 bps to 178.29% in 2026.
• The last three EBT Margin figures came in at 178.29% (Q1 2026), 110.65% (Q4 2025), and 146.68% (Q3 2025), per Business Quant data.